CRO Laboratory Division: Transition and Strategic Focus
Until July 2023, LSB MedTech Ltd (formerly Life Science Business Ltd) provided Clinical Research Organization (CRO) services for pharmaceutical companies and the medical technology sector. These activities included the design, execution and data analysis of clinical studies supporting regulatory submissions, market access and the development of emerging medical and pharmaceutical technologies.
In July 2023, the CRO laboratory activities were acquired by an external party. Following this transition, LSB MedTech has strategically refocused its operations on medical technology innovation and the valorisation of intellectual property. This shift reflects our long-term commitment to advancing technological development within the MedTech sector through research, concept development and collaborative innovation.
This website is intended exclusively for business-to-business (B2B) communication.
The information provided is aimed at professional partners, research institutions, healthcare organizations and companies involved in innovation, valorisation and technology development. It is not intended for patients or general consumer use.
Confidentiality Notice
Due to the confidential nature of our patents, inventions, and R&D activities, not all projects and development phases are publicly disclosed.
EU-office:
Coolsingel 104
3011 AG Rotterdam